Psoriasis Drugs Market is predicted to progress at a CAGR of 6.5% to reach a valuation of US$ 21.48 Bn by 2031
10. März 2022 11:30 ET
|
Persistence Market Research
NEW YORK, March 10, 2022 (GLOBE NEWSWIRE) -- Psoriasis is a chronic inflammatory skin disease that occurs due to genetic disposition and environmental factors. Psoriasis is a systemic disease...